| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |